Mackenzie Financial Corp Raises Position in Teleflex Incorporated (NYSE:TFX)

Mackenzie Financial Corp lifted its stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) by 59.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 36,281 shares of the medical technology company's stock after acquiring an additional 13,488 shares during the quarter. Mackenzie Financial Corp owned about 0.08% of Teleflex worth $6,457,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in TFX. Norges Bank bought a new position in Teleflex in the 4th quarter valued at $100,328,000. Invesco Ltd. increased its position in shares of Teleflex by 48.1% in the fourth quarter. Invesco Ltd. now owns 1,068,593 shares of the medical technology company's stock valued at $190,188,000 after acquiring an additional 347,003 shares during the last quarter. Diamond Hill Capital Management Inc. acquired a new position in Teleflex during the fourth quarter worth approximately $46,696,000. T. Rowe Price Investment Management Inc. boosted its holdings in shares of Teleflex by 4.4% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company's stock worth $1,098,693,000 after acquiring an additional 261,279 shares during the period. Finally, Magnetar Financial LLC boosted its holdings in shares of Teleflex by 105.2% during the fourth quarter. Magnetar Financial LLC now owns 421,340 shares of the medical technology company's stock worth $74,990,000 after acquiring an additional 215,961 shares during the period. Institutional investors and hedge funds own 95.62% of the company's stock.

Teleflex Stock Down 0.3%

Shares of TFX stock traded down $0.34 on Friday, reaching $122.19. 683,821 shares of the company were exchanged, compared to its average volume of 629,565. The company has a market cap of $5.40 billion, a price-to-earnings ratio of 24.29, a PEG ratio of 1.73 and a beta of 1.17. The company has a 50-day moving average of $129.59 and a 200-day moving average of $157.49. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. Teleflex Incorporated has a one year low of $119.08 and a one year high of $249.91.

Teleflex (NYSE:TFX - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share for the quarter, beating the consensus estimate of $2.88 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The business had revenue of $700.67 million for the quarter, compared to analysts' expectations of $699.37 million. During the same quarter last year, the firm earned $3.21 EPS. The firm's revenue for the quarter was down 5.0% compared to the same quarter last year. Analysts anticipate that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Tuesday, May 20th will be given a dividend of $0.34 per share. The ex-dividend date is Tuesday, May 20th. This represents a $1.36 annualized dividend and a dividend yield of 1.11%. Teleflex's dividend payout ratio is currently 42.90%.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on TFX. Royal Bank of Canada lowered their price target on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating for the company in a report on Friday, May 2nd. Truist Financial decreased their price objective on Teleflex from $140.00 to $137.00 and set a "hold" rating for the company in a report on Monday, May 5th. Wells Fargo & Company decreased their price objective on Teleflex from $146.00 to $137.00 and set an "equal weight" rating for the company in a report on Friday, May 2nd. Wall Street Zen downgraded Teleflex from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Finally, Citizens Jmp downgraded Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Hold" and a consensus target price of $164.63.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.